Market research
228760.KO Genomictree Inc.
KO KRW Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 228760.KO discussion.
5 years, 5 months ago
Genomictree Inc. is currently in a long term downtrend where the price is trading 0.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Genomictree Inc.'s total revenue rose by 316.1% to $572M since the same quarter in the previous year.
Its net income has increased by 73.2% to $-1B since the same quarter in the previous year.
Finally, its free cash flow grew by 81.3% to $-2B since the same quarter in the previous year.
Based on the above factors, Genomictree Inc. gets an overall score of 4/5.